[March 11, 2014]

Research and Markets: Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018

Research and Markets (http://www.researchandmarkets.com/research/rx3gd8/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering.

The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis (News - Alert), and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment.

The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Tumor Profiling Technology Landscape

4 Tumor Profiling Research Portfolio

5 Value Chain Analysis

6 Market Landscape Analysis

7 Technology Adoption And Development Potential, By Geography

8 Technology Investment Analysis

9 Competitive Landscape Analysis

10 Patent Analysis

11 Analyst Insights And Recommendations

12 Company Profiles

Companies Mentioned:

• Agendia Nv
• Biotheranostics
• Boreal Genomics, Inc
• Caris Life Sciences
• Genomic Health, Inc
• Illumina, Inc
• Life Technologies Corporation
• Nanostring Technologies
• Neogenomics Laboratories
• Oncopath Laboratory
• Oxford Gene Technology Ltd
• Precision Therapeutics, Inc
• Proteome Sciences Plc
• Rational Therapeutics
• Ribomed Biotechnologies

For more information visit http://www.researchandmarkets.com/research/rx3gd8/cancertumor

[ Back To TMCnet.com's Homepage ]